Protein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropin

Molecular Pharmacology

Volumn 76, Issue 5, 2009, Pages 1123-1129

  Vuchak, Lisa A ^a   Tsygankova, Oxana M ^a   Prendergast, Gregory V ^a,b   Meinkoth, Judy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; B RAF KINASE; BUTYRYL CYCLIC AMP; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAP1 PROTEIN; RAS PROTEIN; THYROTROPIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE SILENCING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; THYROID CELL;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA REPLICATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS B-RAF; RATS; RATS, WISTAR; THYROTROPIN;

EID: 70350440275     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.060129     Document Type: Article

References (39)

1. al-Alawi N, Rose DW, Buckmaster C, Ahn N, Rapp U, Meinkoth J, and Feramisco JR (1995) Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade. Mol Cell Biol 15:1162-1168.
2. Ambrosini A, Tininini S, Barassi A, Racagni G, Sturani E, and Zippel R (2000) cAMP cascade leads to Ras activation in cortical neurons. Brain Res Mol Brain Res 75:54-60. (Pubitemid 30058325)
3. Boikos SA and Stratakis CA (2007) Carney complex: the first 20 years. Curr Opin Oncol 19:24-29.
4. Cass LA and Meinkoth JL (1998) Differential effects of cyclic adenosine 3′,5′- monophosphate on p70 ribosomal S6 kinase. Endocrinology 139:1991-1998.
5. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, and Meinkoth JL (1999) Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 19:5882-5891.
6. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, and Avvedimento EV (2001) cAMP signaling selectively influences Ras effectors pathways. Oncogene 20:1186-1192. (Pubitemid 32226244)
7. De Gregorio G, Coppa A, Cosentino C, Ucci S, Messina S, Nicolussi A, D'Inzeo S, Di Pardo A, Avvedimento EV, and Porcellini A (2007) The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene 26:2039-2047. (Pubitemid 46514747)
8. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, and Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477. (Pubitemid 28553318)
9. Dremier S, Milenkovic M, Blancquaert S, Dumont JE, Døskeland SO, Maenhaut C, and Roger PP (2007) Cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells. Endocrinology 148:4612-4622. (Pubitemid 47481556)
10. Dremier S, Vandeput F, Zwartkruis FJ, Bos JL, Dumont JE, and Maenhaut C (2000) Activation of the small G protein Rap1 in dog thyroid cells by both cAMPdependent and -independent pathways. Biochem Biophys Res Commun 267:7-11. (Pubitemid 30072498)
11. Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA, Bastian BC, Springer C, and Marais R (2006) In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res 66:9483-9491. (Pubitemid 44623646)
12. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Døskeland SO, Blank JL, and Bos JL (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4:901-906. (Pubitemid 35331366)
13. Hochbaum D, Hong K, Barila G, Ribeiro-Neto F, and Altschuler DL (2008) Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMPmediated mitogenesis. J Biol Chem 283:4464-4468.
14. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, and De Blasi A (2001) Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60:924-933. (Pubitemid 33027427)
15. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, and Graybiel AM (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279. (Pubitemid 29004080)
16. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, and Roger PP (2001) Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656. (Pubitemid 32955247)
17. Kondo T, Ezzat S, and Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306.
18. Kupperman E, Wen W, and Meinkoth JL (1993) Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Mol Cell Biol 13:4477-4484. (Pubitemid 23220355)
19. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, and Schultz G (1996) The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci U S A 93:116-120. (Pubitemid 26038113)
20. Medina DL and Santisteban P (2000) Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143:161-178.
21. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, and Cheng X (2002) Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277:11497-11504. (Pubitemid 34952919)
22. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, et al. (2005) The RET/PTC-RASBRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081. (Pubitemid 40489412)
23. Miller KA, Yeager N, Baker K, Liao XH, Refetoff S, and Di Cristofano A (2009) Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res 69:3689-3694.
24. Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA, and Meinkoth JL (1998) Differential effects of protein kinase A on Ras effector pathways. Mol Cell Biol 18:3718-3726. (Pubitemid 28287893)
25. Mitsutake N, Knauf JA, Mitsutake S, Mesa C, Jr., Zhang L, and Fagin JA (2005) Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 65: 2465-2473. (Pubitemid 40490159)
26. Obara Y, Horgan AM, and Stork PJ (2007) The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells. J Neurochem 101:470-482. (Pubitemid 46525282)
27. Pak Y, Pham N, and Rotin D (2002) Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation. Mol Cell Biol 22:7942-7952. (Pubitemid 35217303)
28. Pham N, Cheglakov I, Koch CA, de Hoog CL, Moran MF, and Rotin D (2000) The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP. Curr Biol 10:555-558. (Pubitemid 30308317)
29. Ribeiro-Neto F, Urbani J, Lemee N, Lou L, and Altschuler DL (2002) On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proc Natl Acad Sci U S A 99:5418-5423. (Pubitemid 34411563)
30. Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O, and Stratakis CA (2002) Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer 35:182-192. (Pubitemid 34919976)
31. Stork PJ and Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266. (Pubitemid 34634174)
32. Tsygankova OM, Kupperman E, Wen W, and Meinkoth JL (2000) Cyclic AMP activates Ras. Oncogene 19:3609-3615.
33. Tsygankova OM, Prendergast GV, Puttaswamy K, Wang Y, Feldman MD, Wang H, Brose MS, and Meinkoth JL (2007) Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol 27:6647-6658. (Pubitemid 47483619)
34. Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA, and Meinkoth JL (2001) Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol Cell Biol 21:1921-1929. (Pubitemid 32479616)
35. Vandeput F, Perpete S, Coulonval K, Lamy F, and Dumont JE (2003) Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′- monophosphate and growth factors. Endocrinology 144:1341-1349. (Pubitemid 36428476)
36. Wang B, Yang Y, and Friedman PA (2008) Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. Mol Biol Cell 19:1637-1645. (Pubitemid 351805116)
37. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-262.
38. Yang H, Cooley D, Legakis JE, Ge Q, Andrade R, and Mattingly RR (2003) Phosphorylation of the Ras-GRF1 exchange factor at Ser916/898 reveals activation of Ras signaling in the cerebral cortex. J Biol Chem 278:13278-13285. (Pubitemid 36800098)
39. Yeager N, Brewer C, Cai KQ, Xu XX, and Di Cristofano A (2008) Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium. Cancer Res 68:444-449.